Cited by 1,234Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk FactorsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

Development and Validation of the American Heart Association’s PREVENT Equations

Open access

Khan, Sadiya S., Matsushita, Kunihiro, Sang, Yingying, Ballew, Shoshana H., Grams, Morgan E., Surapaneni, Aditya, Blaha, Michael J., Carson, April P., Chang, Alexander R., Ciemins, Elizabeth, Go, Alan S., Gutierrez, Orlando M., Hwang, Shih-Jen, Jassal, Simerjot K., Kovesdy, Csaba P., Lloyd-Jones, Donald M., Shlipak, Michael G., Palaniappan, Latha P., Sperling, Laurence, Virani, Salim S., Tuttle, Katherine, Neeland, Ian J., Chow, Sheryl L., Rangaswami, Janani, Pencina, Michael J., Ndumele, Chiadi E., Coresh, Josef, for the Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group·2024·Circulation

DOI 10.1161/circulationaha.123.067626PMC PMC10910659

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations. Therefore, we developed and validated the American Heart Association Predicting Risk of CVD EVENTs (PREVENT) equations among US adults 30 to 79 years of age without known CVD. METHODS: The derivation sample included individual-level participant data from 25 data sets (N=3 281 919) between 1992 and 2017. The primary outcome was CVD (atherosclerotic CVD and heart failure). Predictors included traditional risk factors (smoking status, systolic blood pressure, cholesterol, antihypertensive or statin use, and diabetes) and estimated glomerular filtration rate. Models were sex-specific, race-free, developed on the age scale, and adjusted for competing risk of non-CVD death. Analyses were conducted in each data set and meta-analyzed. Discrimination was assessed using the Harrell C-statistic. Calibration was calculated as the slope of the observed versus predicted risk by decile. Additional equations to predict each CVD subtype (atherosclerotic CVD and heart failure) and include optional predictors (urine albumin-to-creatinine ratio and hemoglobin A1c), and social deprivation index were also developed. External validation was performed in 3 330 085 participants from 21 additional data sets. RESULTS: Among 6 612 004 adults included, mean±SD age was 53±12 years, and 56% were women. Over a mean±SD follow-up of 4.8±3.1 years, there were 211 515 incident total CVD events. The median C-statistics in external validation for CVD were 0.794 (interquartile interval, 0.763–0.809) in female and 0.757 (0.727–0.778) in male participants. The calibration slopes were 1.03 (interquartile interval, 0.81–1.16) and 0.94 (0.81–1.13) among female and male participants, respectively. Similar estimates for discrimination and calibration were observed for atherosclerotic CVD– and heart failure–specific models. The improvement in discrimination was small but statistically significant when urine albumin-to-creatinine ratio, hemoglobin A1c, and social deprivation index were added together to the base model to total CVD (ΔC-statistic [interquartile interval] 0.004 [0.004–0.005] and 0.005 [0.004–0.007] among female and male participants, respectively). Calibration improved significantly when the urine albumin-to-creatinine ratio was added to the base model among those with marked albuminuria (>300 mg/g; 1.05 [0.84–1.20] versus 1.39 [1.14–1.65]; P =0.01). CONCLUSIONS: PREVENT equations accurately and precisely predicted risk for incident CVD and CVD subtypes in a large, diverse, and contemporary sample of US adults by using routinely available clinical variables.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.123.067626

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citation
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Self-citation
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Self-citation
Association between Water Intake, Chronic Kidney Disease, and Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data
Sontrop, J. M., Dixon, S. N., Garg, A. X., Jiménez, I. B., Dohein, O., Huang, S. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,903
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Self-citation
New creatinine- and cystatin C-based equations to estimate GFR without race
Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102953 · Cited by 4,695
Self-citation
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
Self-citation
Untitled work
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Self-citation

Show all 92 references

Sorted by citations

Items 301–400 of 1,000

Validation and Recalibration of PCE, China-PAR, and PREVENT Models for Estimating ASCVD Risk in China
Li, H., Chen, S., Zhang, R., Tian, X., Wu, S., & Wang, A. (2026) · JACC Asia · doi:10.1016/j.jacasi.2025.12.015 · Cited by 6
Cardiovascular risk prediction in women: rethinking traditional approaches through precision medicine
Dakhil, Z. A., Gitti, S. A., & Kaddoura, R. (2026) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2026.1659244 · Cited by 6
Aortic and Cardiac Structure From Routine CT Predict Cardiovascular Risk Beyond PREVENT and Coronary Calcium
Oo, D. W., Jung, M., Nürnberg, L., Chandra, J., Sturniolo, A., Kerkovits, N. M., Jorshery, S. D., Langenbach, M. C., Foldyna, B., Kiel, D. P., et al. (2026) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2026.01.006 · Cited by 7
Incorporating polygenic risk scores and social determinants of health across populations: Considerations and best practices in research
CROMER, S. J., Cobran, E. K., Iyer, H. S., Hysong, M. R., Vargas, L. B., Smith, J. L., Konigsberg, I. R., Bogumil, D. D., Glover, L. M., King, G. A., et al. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.02.007 · Cited by 7
Early Prediction of Heart Failure From Routine Cardiac CT Using Radiomic Phenotyping of Epicardial Fat
Oikonomou, E. K., Chan, K., Patel, P., Wahome, E., Dangas, K., Desai, R., Sobirov, I., Khera, R., Petersen, S. E., Pugliese, F., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.02.5116 · Cited by 6
Performance of PREVENT Cardiovascular Risk in Electronic Health Record–Based Clinical Practice
Hong, C., Niu, M., Wang, H.-Y., Wojdyla, D. M., Economou-Zavlanos, N. J., Engelhard, M., Pignone, M., Patel, M. R., & Pencina, M. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.6838 · Cited by 6
Self-citation
A Novel Breast Arterial Calcification Age-Based Percentile Nomogram for the Incremental Prediction of Incidental Cardiovascular Events
Nerlekar, N., Soh, C. H., Vasanthakumar, S. A., Goel, V., Mantey, R., Wang, J., Aldous, E., Nandurkar, R., Arnott, C. G., Bui, Q. M., et al. (2026) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2026.03.008 · Cited by 7
Advances in the diagnosis and detection of chronic kidney disease
Lees, J. S., Zhang, L., Anandh, U., Kronbichler, A., Fisher, L.-A., Borg, M., Wang, A. Y.-M., & Levin, A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00702-6 · Cited by 6
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Khan, S. S., Bhave, N. M., Blumenthal, R. S., Coresh, J., Huang, X., Joseph, J. J., Khera, A., Ho, J. E., Lloyd‐Jones, D. M., Wang, C. C. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001447 · Cited by 11
Self-citation
Advances in predicting cardiovascular risk: Applying the PREVENT equations
Garba, D. L., Razavi, A. C., Blumenthal, R. S., Stone, N. J., Polonsky, T. S., Khan, S. S., & Barouch, L. A. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100705 · Cited by 7
Self-citation
Improving Cardiovascular Disease Primary Prevention Treatment Thresholds in a New England Health Care System
Cho, S. M. J., Rivera, R., Koyama, S., Kim, M. S., Ganesh, S., Bhattacharya, R., Paruchuri, K., Masson, P. R., Honigberg, M. C., Allen, N. B., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101257 · Cited by 6
Nonlinearity of the inverse relationship between high-density lipoprotein (HDL) cholesterol and incident cardiovascular risk: Is it time to revisit the “HDL hypothesis”?
Hashem, C., Altin, S. E., Guyton, J. R., & Boden, W. E. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.12.009 · Cited by 7
Adding social determinants of health to the equation: Development of a cardiometabolic disease staging model using clinical and social determinants of health to predict type 2 diabetes
Howell, C. R., Tanaka, S., Zhang, L., Carson, A. P., Yi, N., Shikany, J. M., Garvey, W. T., & Cherrington, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16241 · Cited by 5
Self-citation
Chronic kidney disease is no longer a ‘non-traditional’ cardiac risk factor: a call to action for cardiovascular-kidney-metabolic health
Fong, J. M. N., Sia, C., & See, K. C. (2025) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2025-012 · Cited by 5
Future of Stroke Prevention
Razavi, A. C., Troy, A. L., Patel, J., Mehta, L. S., Spitz, J. A., Lloyd‐Jones, D. M., Whelton, S. P., Johansen, M. C., & Blumenthal, R. S. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101724 · Cited by 8
Self-citation
Treating Hypercholesterolemia in Older Adults for Primary Prevention of Cardiovascular Events
Al-Ani, A., Jamil, Y., & Orkaby, A. R. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01139-4 · Cited by 6
LDL-C targets based on coronary artery calcium: advancing Figure 6 from the 2022 American college of cardiology expert consensus decision pathway
Burka, S., Aneni, E. C., Leucker, T. M., & Blaha, M. J. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101047 · Cited by 6
Self-citation
Complex interactions and composite burden of risk factors in vascular cognitive impairment
Ji, L., & Zhang, J. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123367 · Cited by 6
Contrast-enhancing Lesions Induced by Central Nervous System-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes
Gal, O., Yu, J., Mehta, M. P., Hall, M. D., Press, R. H., Odia, Y., McDermott, M. W., Fellows, Z. T., Wroe, A. J., Gutiérrez, A. N., et al. (2025) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2025.03.025 · Cited by 5
Development and validation of the CARE-DM model to predict the cardiovascular risk in older persons with type 2 diabetes
Ribero, V. A., Efthimiou, O., Alwan, H., Bauer, D. C., Henrard, S., Waeber, G., Marques-Vidal, P. M., Rodondi, N., Giovane, C. D., & Gencer, B. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf296 · Cited by 5
Performance of SCORE2, QRISK3 and PREVENT equations in systemic lupus erythematosus
Azoulay, L.-D., Broussaud, T., Kachenoura, N., Mathian, A., Pha, M., Hié, M., Abdallah, N. A., de Chambrun, M. P., Papo, M., Aubart, F. C., et al. (2025) · Lupus · doi:10.1177/09612033251356138 · Cited by 5
Incidental Finding of Coronary and Non-Coronary Artery Calcium: What Do Clinicians Need To Know?
Haudenschild, C., Parsa, S., & Rodriguez, F. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01318-7 · Cited by 5
Optimizing long term disease prevention with reinforcement learning: a framework for precision lipid control
Zhou, Y., Luo, R., Blais, J. E., Tan, K. C. B., Lui, D. T. W., Yiu, K. H., Lai, F. T. T., Wan, E. Y. F., Cheung, C., Wong, I. C. K., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01951-1 · Cited by 7
Cardiovascular-kidney-metabolic syndrome stage predicts cardiovascular outcomes in cancer patients: a real-world data analysis of a nationwide epidemiological dataset
Ko, T., Suzuki, Y., Kaneko, H., Okada, A., Jimba, T., Azegami, T., Mizuno, A., Ejiri, K., Fujiu, K., Takeda, N., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf115 · Cited by 5
Incidence of Heart Failure in Asian American, Native Hawaiian, and Other Pacific Islander Populations
Ambrosy, A. P., Daida, Y. G., Parikh, R., Tan, T. C., Howick, C. K., Alexeeff, S., Lo, J. C.-M., & Go, A. S. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.047 · Cited by 5
Self-citation
Environment-wide association study of cardiovascular-kidney-metabolic syndrome based on NHANES 2013–2016
Ma, J., Li, P., Tao, L., Yang, X., Luo, Y., Guo, X., & Gao, B. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118993 · Cited by 6
Role of Morbidity Clusters in Midlife on Ischemic Stroke Incidence and Severity: The ARIC Study
Egle, M. S., Groechel, R. C., Johansen, M. C., Kucharska‐Newton, A., Gottesman, R. F., & Koton, S. (2025) · Stroke · doi:10.1161/strokeaha.124.049496 · Cited by 5
Validation of the American Heart Association Predicting Risk of Cardiovascular Disease Events Equations in Diverse Socioeconomic Groups: The All of Us Cohort
Lewis, A. A., Bacong, A. M., Palaniappan, L. P., & Hernandez‐Boussard, T. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041549 · Cited by 5
Self-citation
Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort
Llorca, J., Ferraz‐Amaro, I., Castañeda, S., Plaza, Z., Sánchez‐Alonso, F., Gómez, M. C. G., González‐Juanatey, C., & González-Gay, M. Á. (2025) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2025.152833 · Cited by 5
External validation of the American heart association’s PREVENT equations in predicting atherosclerotic cardiovascular disease risk among Arab women and men: a retrospective cohort study
Al-Shamsi, S., & Govender, R. D. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05211-8 · Cited by 5
Projected Impact of 2025 AHA/ACC High Blood Pressure Guideline on Medication Use
Zhang, Y., & An, J. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25903 · Cited by 5
Association of the cardiovascular–kidney–metabolic syndrome and adverse outcomes after noncardiac surgery
Glance, L. G., Maddox, K. E. J., Cavanaugh, S. M., Knight, P. A., Mazzeffi, M. A., Shang, J., Stone, P. W., Lustik, S. J., Panda, K., Kreso, M. A., et al. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.10.011 · Cited by 6
Impact of Smartphone-Enabled Home Urinary Albumin-Creatinine Ratio Testing on Albuminuria Screening and Management
Zafar, W., Hu, Y., Brubaker, L., Harshaw, N., Green, J. A., & Chang, A. R. (2025) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2025.09.019 · Cited by 5
Self-citation
Sarcopenia risk along the cardiovascular-kidney-metabolic syndrome spectrum: synergistic effects of multisystem burden and physical inactivity
Wang, D., Zhang, M., Fan, Q., Yu, J., Li, J., Jiang, L., Zheng, X., Ye, S., Li, S., Xie, P., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-25740-3 · Cited by 5
Joint associations of accelerometer-measured physical activity and cardiovascular-kidney-metabolic syndrome stages with the risks of cancer and all-cause mortality
Liu, J.-C., Yang, R., Feng, Z.-F., Liu, B.-Q., Yu, L., Chen, Y.-H., Li, D.-R., Zheng, W.-R., Liu, N., Gao, S., et al. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf365 · Cited by 5
Rest-activity rhythms and cardiovascular events in cardiovascular–kidney–metabolic syndrome: evidence from two nationwide cohorts
Weng, B., Chen, H., Chen, H., Wang, N., Feng, H., Yang, K., & Tan, X. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101414 · Cited by 5
PREVENT Equation Performance in Asian and Native Hawaiian and Other Pacific Islander Groups
Au, M., Zhang, Y., Zhou, M. M., Choi, S. K., Zhou, H. C., Harrison, T. N., Mefford, M. T., Lee, M. S., Yang, E., Shah, N. S., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.56915 · Cited by 5
Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3
Weng, B., Wei, J., Chen, H., Zhao, Y., Wang, N., Feng, H., Ai, S., & Tan, X. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156600 · Cited by 5
Development and Validation of a Parsimonious Risk Stratification Model for Pancreatic Cancer
Mavromatis, L. A., Zlatanic, V., Agarunov, E., Sanoba, S. A., Kluger, M. D., Horwitz, L. I., Razavian, N., Maitra, A., Gonda, T. A., & Grams, M. E. (2026) · JAMA Oncology · doi:10.1001/jamaoncol.2026.0372 · Cited by 5
Self-citation
ACADM-mediated fatty acid β-oxidation pathway in atherosclerosis and abdominal aortic aneurysm
Zhang, H., Sun, L., Xu, T., Hou, X., Zhong, F., Shi, F., Chen, Y., Li, Y. M., Wang, Y., Lyu, Y., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag372 · Cited by 6
Prevalence of Silent Atherosclerosis across Adult Life
Bundgaard, H., García‐Lunar, I., Kofoed, K. F., Hasselbalch, R. B., Pérez‐García, C. N., Kunkel, J. B., Stæger, F. F., Sánchez‐Cabo, F., Fuster, J. J., Mass, V., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2609059 · Cited by 8
Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population
Kosyakovsky, L. B., de Boer, R. A., & Ho, J. E. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-024-00686-6 · Cited by 6
PREVENT Equation: The Black Sheep among Cardiovascular Risk Scores? A Comparative Agreement Analysis of Nine Prediction Models in High-Risk Lithuanian Women
Navickas, P., Lukavičiūtė, L., Glaveckaitė, S., Baranauskas, A., Šatrauskienė, A., Badarienė, J., & Laucevičius, A. (2024) · Medicina · doi:10.3390/medicina60091511 · Cited by 5
Renal arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis
Garg, S., Astor, B. C., Lim, S. S., Raval, A. N., Zhong, W., Panzer, S. E., Khosroshahi, A., Rovin, B. H., & Bartels, C. M. (2024) · Rheumatology · doi:10.1093/rheumatology/keae699 · Cited by 5
Differences in Statin Eligibility With the Use of Predicting Risk of Cardiovascular Disease EVENTs Versus Pooled Cohort Equations in the UK Biobank
Dhaliwal, J. S., Gaonkar, M. P., Patel, N. B., Shetty, N. S., Li, P., Vekariya, N., Kalra, R., Arora, G., & Arora, P. K. (2025) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2024.12.034 · Cited by 5
Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)
Giannakopoulou, S., Barkas, F., Chrysohoou, C. A., Liberopoulos, E. N., Sfikakis, P. P., Pitsavos, C., Tsioufis, C., & Panagiotakos, D. B. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.02.007 · Cited by 6
Prediction of Cardiovascular Risk Among People with HIV Using the PREVENT Equations Compared to the Pooled Cohort Equations
Durstenfeld, M. S., McLaughlin, M. M., Gandhi, M., Kornak, J., Beatty, A. L., & Hsue, P. Y. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09642-z · Cited by 5
Implementing the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Leveraging Evidence to Push the Boundaries of Clinical Care
McCarthy, C. P., McEvoy, J. W., & Cluett, J. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25418 · Cited by 7
The Role of the Parametric Thyroid Feedback Quantile Index in Cardiovascular Risk Evaluation Among Euthyroid Koreans
Choe, H. J., Choi, Y. M., Ha, Y., Kim, J., Kim, M., Cha, H. J., Lee, J., Kwak, M. K., & Hong, E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf046 · Cited by 4
Reduced Risk of Cardiovascular Diseases after Bariatric Surgery Based on the New PREVENT EquationsPreprint
Wang, L., Zhang, X., Chen, Y., Flynn, C. R., English, W. J., Samuels, J. M., Williams, B., Spann, M. D., Albaugh, V. L., Shu, X., et al. (2024) · medRxiv · doi:10.1101/2024.08.05.24311527 · Cited by 5
The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise—But More Complicated—Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment
Watson, K. E., & Fonarow, G. C. (2026) · Circulation · doi:10.1161/circulationaha.126.079538 · Cited by 5
Association of neighborhood-level socioeconomic disadvantage and Life's Essential 8 in early pregnancy
Venkatesh, K. K., Grobman, W. A., Huang, X., Yee, L. M., Catov, J. M., Simhan, H., Haas, D. M., Mercer, B. M., Reddy, U. M., Silver, R. M., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100925 · Cited by 4
Self-citation
Sex and racial differences in prevalence and clinical characteristics of people living with LDLR and PCSK9 familial hypercholesterolemia genetic variants: Data from the All of Us Research program
Osei, J., Razavi, A. C., Quyyumi, A. A., Eapen, D. J., Sun, Y. V., Khoury, M. J., & Sperling, L. S. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101024 · Cited by 4
Self-citation
The Advanced Lung Cancer Inflammation Index and Mortality in Patients with Cardiovascular-Kidney Metabolic Syndrome: Insights from NHANES
Ma, X., Tang, X., Chen, S., Wu, T., Zuo, P., Wu, F., Hou, E., & Zhang, X. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05019-6 · Cited by 4
Trends in obesity and heart failure-related mortality in middle-aged and young adult populations of the united states, 1999–2022
Jabbar, A. B. A., Mansoor, T., Osborne, J., Gilkeson, K., Chinawalkar, A., & Aboeata, A. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05029-4 · Cited by 4
Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation
Li, X., Zhao, W., Li, Z., Sun, T., Pan, H., & Wang, D. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70043 · Cited by 6
The impact of short-term comprehensive treatment on cardiovascular-kidney-metabolic syndrome and its components in patients with type 2 diabetes
Gong, L., Yang, R., Cui, H., Zhao, J., Liu, J., Lv, X., & Ding, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1659340 · Cited by 5
Beyond Racial Categorization in Sports Cardiology: A Systematic Review of Cardiac Adaptations in Athletes
Corsi, D. R., Hernandez, R., Bao, J. Y., Garrova, S., & Shipon, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14197107 · Cited by 4
Cardiovascular risk assessment enhanced by automated machine learning in a multi-phase study
Bibi, I., Schaffert, D., Blanke, P., Illian, L., Lenzing, F., Martin, N., Leipe, J., März, W., Stach, K., & Olsavszky, V. (2025) · Scientific Reports · doi:10.1038/s41598-025-24189-z · Cited by 4
Plant-based diet and mortality in adults with cardiovascular-kidney-metabolic syndrome: evidence from NHANES with mediation by leukocyte telomere length
Xiao, Z., Chen, F., Yin, Y., You, B., Wang, Y., & Sun, B. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2586326 · Cited by 4
Hypertension in the Oldest Old
Supiano, M. A., Ascher, S. B., & Rich, M. W. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.102306 · Cited by 7
2025 Brazilian evidence-based guideline on the management of obesity and prevention of cardiovascular disease and obesity-associated complications: a position statement by five medical societies
Valério, C. M., Saraiva, J. F. K., Valente, F., van de Sande‐Lee, S., Rocha, V. Z., Rached, F. H., Drager, L. F., Halpern, B., Júnior, W. S. D. S., Trujilho, F. R., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01954-8 · Cited by 8
Association Between Left Ventricular Global Longitudinal Strain and Hepatic Inflammation and Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Hüning, A. R., Rosa, V. E. E., Piardi, D. S., Assis, D. V. R., Ferreira, T., Griseli, L., Moreira, F. C., Carli, L. A. D., Hartmann, C. R., Coral, G. P., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15233007 · Cited by 4
Evaluation of the PREVENT Equations in a Nationwide Cohort of 7.7 Million Korean Adults
Lee, H., Inoue, K., Son, D., Mori, Y., Yang, E., Yano, Y., Kim, H. C., Kazi, D. S., Lloyd‐Jones, D. M., & Khan, S. S. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.1591 · Cited by 4
Self-citation
Data-driven phenotypic profiling of prediabetes reveals heterogeneous cardiometabolic risks in Chinese adults
Jia, X., Wang, S., Wang, J., Ding, Y., Li, M., Lin, Y., Zheng, R., Huang, F., Wei, H., Hu, C., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03008-9 · Cited by 5
Circulating cardiovascular biomarkers in motion: redefining cardiovascular risk with dynamic prediction
de Bakker, M., Gordon, B., Shah, A. S. V., Boersma, E. H., & Kimenai, D. M. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf764 · Cited by 6
Association Between Uterine Fibroids and Risk of Atherosclerotic Cardiovascular Disease
DiTosto, J. D., Lewey, J., Zee, J., Dokras, A., Busse, K. R., Alur-Gupta, S., Hinkle, S. N., Schisterman, E. F., Mumford, S. L., & Caniglia, E. C. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.044014 · Cited by 4
Metabolomics in cardiovascular diseases: from prevention strategies to domain-specific applications
Zhao, Q., Pang, Y. Y., Lim, R. L., Tham, W. K., & Choi, H. (2025) · Expert Review of Proteomics · doi:10.1080/14789450.2025.2606050 · Cited by 5
Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome
Gregg, L. P., Bozkurt, B., & Navaneethan, S. D. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000973 · Cited by 4
Myeloid inflammation thresholds stratify mortality risk in early-stage cardiovascular-kidney-metabolic syndrome: MLR-driven findings from NHANES
Qu, Y., Wang, L., Liu, L., & Sun, Y. (2025) · Immunologic Research · doi:10.1007/s12026-025-09707-5 · Cited by 4
Sex differences in cardiac risk and kidney function: serum creatinine versus cystatin C
Mata, N. L. D. L., Hedley, J., Webster, A. C., Sullivan, M. K., Rosales, B. M., Mark, P. B., & Lees, J. S. (2025) · BMC Medicine · doi:10.1186/s12916-025-04588-9 · Cited by 4
Ancestry gaps in cardiovascular GWAS: a multi-database review of African representation in genomic studies
Pomales-Matos, D. A., Lyerly, M., Rivera-Madera, A., Echevarría-Bonilla, O. L., Alvarez-Cortes, M., Henriquez-Quiñones, S. E., Reyes-Sosa, G. M., Villanueva-Nogueras, R. A., & Peña-Martínez, E. G. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2025.1647176 · Cited by 4
Relationship Between the Severity of Coronary Artery Disease and Renal Function
Karayakalı, M., Kadi, H., Karaman, K., Çelik, A., Özbek, K., Damar, I., Zorlu, Ç., Atmaca, H., Ömür, S., & Önalan, O. (2026) · Angiology · doi:10.1177/00033197261416667 · Cited by 4
Progression of Liver Fibrosis and Liver-Related Event Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease at High Cardiovascular Risk
Zhou, X., Chen, Q., Kim, S. U., Yip, T. C., Petta, S., Nakajima, A., Tsochatzis, E. A., Boursier, J., Bugianesi, E., Hagström, H., et al. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.01.038 · Cited by 5
Drivers of Atherosclerotic Cardiovascular Disease in South Asians
Patel, A., Nicholls, S. J., Chew, D. P., Lin, A., Natarajan, P., Nelson, A. J., & Nerlekar, N. (2026) · JACC Asia · doi:10.1016/j.jacasi.2025.10.024 · Cited by 4
Lifetime Adverse Pregnancy Outcome History and Cardiovascular Risk
Liu, T., Vonen, H. D., Henao, R., Pencina, M. J., Rexrode, K. M., Hong, C., Quist‐Nelson, J., Meng, M., Stuart, J. J., Honigberg, M. C., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.25916 · Cited by 4
Self-citation
Opportunistic Cardiovascular Risk Assessment Using Routine Head CT in the Emergency Department
Zhang, X., Acosta, J., Dogra, S., Silva, E. N., Basu, S., Krumholz, H. M., Khera, R., Rajpurkar, P., & Kim, D. A. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.02.5095 · Cited by 5
Neighborhood Indices, Income, and Cardiovascular-Kidney-Metabolic Syndrome at the Census Tract Level
Krishnan, V., Huang, X., McGowan, C., Shah, N. S., Qureshi, F., Minkovitz, C. S., Kershaw, K. N., Freedman, A. A., Miller, G. E., Lloyd‐Jones, D. M., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.6019 · Cited by 4
Self-citation
Detecting and Mitigating Bias for Inclusive and Trustworthy Clinical Research: A Scientific Statement From the American Heart Association
Zhong, J., Al‐Zaiti, S. S., Bennett, D., Do, S., Gaudino, M. F. L., Gichoya, J. W., Musaad, S. M. A., Narayan, S. M., Sajobi, T. T., Yu, S., et al. (2026) · Circulation Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000101 · Cited by 5
The kidney in the middle: Kidney Disease: Improving Global Outcomes (KDIGO) guidelines address multiple key components of cardiovascular-kidney-metabolic syndrome
Levin, A., Bansal, N., de Boer, I. H., Grams, M. E., Jadoul, M., ter Maaten, J. M., Mustafa, R. A., Rossing, P. R., Cheung, M., King, J. M., et al. (2026) · Kidney International · doi:10.1016/j.kint.2026.03.031 · Cited by 4
Self-citation
A Bayesian framework for longitudinal EHR and genetic discovery
Urbut, S., Ding, Y., Nakao, T., Koyama, S., Misra, A., Jiang, X., Harish, A., Gaffney, L., Hornsby, W., Smoller, J. W., et al. (2026) · Nature · doi:10.1038/s41586-026-10780-5 · Cited by 5
Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults
Sayed, A., Peterson, E. D., & Návar, A. M. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.06.037 · Cited by 4
Low‐Density Lipoprotein Cholesterol, Cardiovascular Risk Factors, and Predicted Risk in Young Adults
Zheutlin, A. R., Luebbe, S. T., Chaitoff, A. M., Stulberg, E. L., & Wilkins, J. T. (2024) · Clinical Cardiology · doi:10.1002/clc.70009 · Cited by 7
Prediction of cardiovascular events and all-cause mortality using race and race-free estimated glomerular filtration rate in African Americans: the Jackson Heart Study
Wang, H., Cai, J., Fan, H., Diamantidis, C. J., Young, B. A., & Bidulescu, A. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1432965 · Cited by 4
Joint association of systemic inflammatory response index and sarcopenia with mortality among individuals with self-reported cancer
Huang, Z., Peng, W., Zhao, M., Gao, B., Qian, J., Zhu, S., Jiang, T., Ren, M., Yusuf, S. A. Y., He, Z., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13653-8 · Cited by 4
Association Between Serum Advanced Glycation End Products and Cardiovascular‐Kidney‐Metabolic ( CKM ) Syndrome: A 3‐Year Longitudinal Cohort Study (2019–2022)
Zhao, H., Zhang, Z. W., Luo, T., Aili, D., Ding, W., Li, Y., Gu, Y., Shulipan, A., He, J., Yu, W., et al. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70137 · Cited by 4
Coronary Artery Calcium for Risk Stratification of Heart Failure Mortality: The Coronary Artery Calcium Consortium
Mhaimeed, O., Dardari, Z., Khorsandi, M., Dzaye, O. D. A., Sharma, K., Nasir, K., Berman, D. S., Budoff, M. J., Shaw, L. J., Rumberger, J. A., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.10.437 · Cited by 4
Self-citation
Correlation and Agreement Between the SCORE2 and PREVENT 10-Year Atherosclerotic Cardiovascular Disease Risk Scores: Insights from Coronary Computed Tomography Angiography
Özpelit, M. E., Çolak, A., Uzumcu, H. I., Kumral, Z., & Özpelit, E. (2024) · Diagnostics · doi:10.3390/diagnostics14232625 · Cited by 4
Difference between estimated glomerular filtration rate based on cystatin C versus creatinine and cardiovascular–kidney–metabolic health
Wu, X., Hu, W., Xu, J., Shen, J., Lin, L., Zhu, J., Wei, T., & Lv, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1477343 · Cited by 4
Is Achieving a Fully Race-Neutral Approach to Lung Function Classification Even Possible?
Adibi, A., Sadatsafavi, M., Brigham, E. P., & Bhatt, S. P. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202408-1599vp · Cited by 4
The Impact of Social Determinants of Health on Timely Detection in Transthyretin Cardiac Amyloidosis
Fahed, G., Jimenez, J. I., Fonseca, M. I. A., Hu, J. C., Spencer‐Bonilla, G., Haddad, F., Moreno, J. E. P., Witteles, R. M., & Alexander, K. M. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2024.11.022 · Cited by 4
AHA PREVENT Equations With Lipoprotein(a) and Risk Assessment for Primary Prevention
Lloyd‐Jones, D. M., & Khera, A. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.1591 · Cited by 4
Self-citation
Exploring the PREVENT HF score and myocardial function among persons with HIV
Walpert, A. R., Gupta, M., Dunderdale, C. N., Haptu, H. H., Manandhar, M., deFilippi, C. R., Burdo, T. H., Lee, H., Kwong, R. Y. K., & Srinivasa, S. (2025) · AIDS · doi:10.1097/qad.0000000000004252 · Cited by 4
Cost‐Effectiveness of Coronary Artery Calcium Scoring for Cardiovascular Disease Prevention in Diabetes: An Analysis From MESA
Ferket, B. S., Hunink, M. G. M., Masharani, U. B., Max, W. B., Yeboah, J., & Fleischmann, K. E. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.041543 · Cited by 5
E pluribus unum
Patel, J., Bhatia, H. S., & Spitz, J. A. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100939 · Cited by 4
preventr: An Implementation of the PREVENT and Pooled Cohort Equations
Mayer, M. G. (2024) · doi:10.32614/cran.package.preventr · Cited by 4
Current approach to atherosclerotic cardiovascular disease risk prediction
Khan, W. J., & Kalra, D. K. (2024) · Future Cardiology · doi:10.1080/14796678.2024.2433349 · Cited by 4
From Innovation to Implementation: Is PREVENT Ready for Clinical Practice?
Lu, Y., & Nasir, K. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.05.031 · Cited by 3
Risk prediction models for incident heart failure: a systematic review and meta-analysis
Navarro, J. A., Doumouras, B. S., Douglas, W. A., Tieu, P., Chan, V., Lau, T. H. A., Bobrowski, D., Yu, C., Wang, C. (., Adam, M., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae666.889 · Cited by 3
Assessing cardiovascular disease risk and social determinants of health: A comparative analysis of five risk estimation instruments using data from the Eastern Caribbean Health Outcomes Research Network
Schwartz, J. I., Howitt, C., Raman, S., Nair, S., Hassan, S., Oladele, C., Hambleton, I. R., Sarpong, D. F., Adams, O. P., Maharaj, R. G., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316577 · Cited by 3

Authors: Khan, S. S., Matsushita, K., Sang, Y., Ballew, S. H., Grams, M. E., Surapaneni, A., Blaha, M. J., Carson, A. P., Chang, A. R., Ciemins, E., Go, A. S., Gutierrez, O. M., Hwang, S.-J., Jassal, S. K., Kovesdy, C. P., Lloyd-Jones, D. M., Shlipak, M. G., Palaniappan, L. P., Sperling, L., Virani, S. S., Tuttle, K., Neeland, I. J., Chow, S. L., Rangaswami, J., Pencina, M. J., Ndumele, C. E., Coresh, J., & for the Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group
Affiliations: Northwestern University (US)
Johns Hopkins University (US)
New York University (US)
University of Mississippi Medical Center (US)
Departments of Nephrology and Population Health Sciences, Geisinger Health, Danville, PA (A.R.C.).
American Medical Group Association (US)
Kaiser Permanente (US)
Departments of Epidemiology and Medicine, University of Alabama at Birmingham (O.M.G.).
National Heart, Lung, and Blood Institute (US)
University of California San Diego (US)
University of Tennessee Health Science Center (US)
Department of Preventive Medicine, Northwestern University, Chicago, IL (D.M.L.-J.).
San Francisco VA Medical Center (US)
Stanford Medicine (US)
Emory University (US)
Aga Khan University (PK)
University of Washington (US)
University Hospitals of Cleveland (US)
Western University of Health Sciences (US)
George Washington University (US)
Duke University (US)
ORCID: Khan, Sadiya S.
Matsushita, Kunihiro
Sang, Yingying
Ballew, Shoshana H.
Grams, Morgan E.
Surapaneni, Aditya
Blaha, Michael J.
Carson, April P.
Chang, Alexander R.
Ciemins, Elizabeth
Go, Alan S.
Gutierrez, Orlando M.
Hwang, Shih-Jen
Jassal, Simerjot K.
Kovesdy, Csaba P.
Lloyd-Jones, Donald M.
Shlipak, Michael G.
Palaniappan, Latha P.
Sperling, Laurence
Virani, Salim S.
Tuttle, Katherine
Neeland, Ian J.
Chow, Sheryl L.
Rangaswami, Janani
Pencina, Michael J.
Ndumele, Chiadi E.
Coresh, Josef
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2024-02-06
Volume: 149
Issue: 6
Pages: 430-449
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.123.067626
PMC: PMC10910659
OpenAlex: W4388573970
Cited by: 1,234
References: 92
Citations by year: 2026: 631 · 2025: 467 · 2024: 134
FWCI: 314.97
Type: journal article
Language: en
Update notices: correction (2024-03-11)
correction (2026-10-14)
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Digital Commons-TMC (Texas Medical Center) (submittedVersion)
eCommons - AKU (Aga Khan University) (submittedVersion)
Funders: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100446)
HHS | NIH | National Heart, Lung, and Blood Institute (R21HL165376)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: PREVENT equations, cardiovascular risk prediction, absolute cardiovascular risk, atherosclerotic cardiovascular disease, heart failure, albumin-creatinine ratio, estimated glomerular filtration rate, social deprivation index, HbA1c, risk discrimination and calibration
MeSH terms: Adult, Aged, Albumins, American Heart Association, Cardiovascular Diseases, Creatinine, Female, Heart Failure, Glycated Hemoglobin, Humans, Male, Middle Aged, Risk Factors, Risk Assessment, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development and Validation of the American Heart Association’s PREVENT Equations

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks